Auxiliary system for rheumatoid arthritis medication

Abstract

The invention provides an auxiliary system for a rheumatoid arthritis medication scheme. The auxiliary system is used for matching similar historical medication schemes, related medication costs and treatment results used for treating historical rheumatoid arthritis patients and judging whether transaminase abnormity occurs or not based on the treatment conditions of current patients, analyzing each historical medication scheme, and determining whether the transaminase abnormity occurs or not according to the analyzed historical medication schemes and the analyzed transaminase abnormity. And obtaining scores or grades of three dimensions of safety, effectiveness and economy of each historical medication scheme. And based on the requirements or tendencies of the patient on the medication schemes in three dimensions of safety, effectiveness and economy, screening out corresponding candidate medication schemes from the historical medication schemes and recommending the candidate medication schemes. According to the technical scheme, by means of the computer technology, the corresponding medication scheme is automatically recommended based on the medication tendency of the rheumatoid arthritis patient, decision assistance is provided, the time for adapting the medication scheme for the patient is saved, and the satisfaction degree of the rheumatoid arthritis patient to the medication scheme is improved.

Description

Technical Field

[0001] The present application relates to the field of computer intelligent assisted decision-making in the medical field, and specifically to an auxiliary system that can scientifically and intelligently assist medical personnel in prescribing medicines for patients with rheumatoid arthritis. Background Art

[0002] Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease characterized by synovial inflammation, which often causes joint pain, swelling, stiffness, deformity and dysfunction. The treatment of rheumatoid arthritis is usually based on drugs. Doctors need to prescribe the corresponding medication plan after comprehensive evaluation based on the severity of the patient's disease, physical condition and other factors. There are many types of prescriptions for the treatment of rheumatoid arthritis, including non-steroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs (DMARDs, including traditional synthetic DMARDs and biological DMARDs), glucocorticoids, etc. DAS28 is a scoring standard for the severity of rheumatoid arthritis recognized by the international academic community. Clinicians usually use this score to judge the degree of disease activity in patients.

[0003] In the actual medical process, after evaluating the severity of the patient's rheumatoid arthritis, the doctor needs to choose a suitable medication plan from the many available drugs. This requires not only considering the therapeutic effect and negative effects of the medication plan on the specific patient, but also often needs to consider the cost burden of the medication. For example, for patients with less favorable economic conditions, they tend to choose a plan with certain therapeutic effects but low medication costs. Therefore, in order to prescribe a medication plan suitable for a specific patient, doctors often need to spend a long time weighing and making decisions between various medication plans.

[0004] In summary, there is an urgent need to provide a computer-assisted system that can comprehensively evaluate the advantages and disadvantages of various rheumatoid arthritis medication regimens, so as to help medical personnel scientifically and efficiently prescribe appropriate medication regimens for different rheumatoid arthritis patients. Summary of the invention

[0005] In view of this, the present application provides an auxiliary system for rheumatoid arthritis medication. The auxiliary system automatically matches the corresponding historical medication plan according to the current patient's medical condition, selects scientific indicators to evaluate and display the advantages and disadvantages of various historical medication plans from the three dimensions of economy, effectiveness and safety, so as to assist medical personnel (doctors) to scientifically and efficiently prescribe appropriate medication plans for different rheumatoid arthritis patients, and meet the personalized needs of different patients for medication plans.

[0006] The auxiliary system for rheumatoid arthritis medication provided by the present invention is implemented as an auxiliary system for rheumatoid arthritis medication. The auxiliary system includes: a patient medication record library, a medication regimen acquisition module, a drug database, a medication regimen analysis module and a medication regimen display module.

[0007] Among them, the patient medication record database is used to record the patient's medication records including the age of the rheumatoid arthritis patient, the severity of the disease during treatment, the medication regimen, and whether the patient's transaminase is abnormal during the medication process.

[0008] The medication regimen acquisition module is used to search the patient medication record library for medication regimens with similar medical conditions based on the current patient's medical condition input by the user, as well as information on changes in the severity of the disease during the implementation of the medication regimen and whether abnormal transaminase is present as evaluation information for the relevant medication regimen.

[0009] The drug database is used to record the information of each drug and its standard price.

[0010] The medication regimen analysis module evaluates the safety, effectiveness and economy of each relevant medication regimen based on the evaluation information of the relevant medication regimen and the drug database.

[0011] The medication regimen display module is used to display the evaluation results of each relevant medication regimen by the medication regimen analysis module.

[0012] Furthermore, the medical condition includes the current DAS28 score of the current patient. The medication regimen search module searches for medication regimens in the patient medication record database that are in the same score range as the current DAS28 score, changes in the DAS28 score during the implementation of the medication regimen, and information on whether transaminase is abnormal as evaluation information of the relevant medication regimen.

[0013] In some embodiments, the medical condition includes the current DAS28 score and age of the current patient. Accordingly, the medication regimen search module searches for medication regimens that are in the same age group as the patient and in the same score range as the current DAS28 score in the patient medication record library, changes in the DAS28 score during the implementation of the medication regimen, and whether the transaminase is abnormal as evaluation information of the relevant medication regimen.

[0014] Obviously, the medical condition may include not only the patient's age and DAS28 score, but also other basic information of the patient, such as the current medication regimen of patients who already have medication regimens. The information included in the medical condition will not be listed in detail here.

[0015] Furthermore, the medication regimen analysis module obtains the safety score or grade of the relevant medication regimen based on whether the patient's transaminase is abnormal during the implementation of the relevant medication regimen and the severity of the abnormal transaminase. The medication regimen analysis module obtains the effectiveness score or grade of the relevant medication regimen based on the average monthly change in the DAS28 score of the patient during the implementation of the relevant medication regimen. The medication regimen analysis module obtains the economic score or grade of the relevant medication regimen based on the average monthly medication expenditure of the patient during the implementation of the relevant medication regimen.

[0016] Furthermore, the medication regimen display module is further provided with a medication regimen screening submodule. The medication regimen screening submodule provides an input interface for a user to input restriction conditions of a rheumatoid arthritis medication regimen, and screens candidate medication regimens from the related medication regimens based on the restriction conditions input by the user. The restriction conditions are used to limit the scores or grades of the safety, effectiveness and economy of the rheumatoid arthritis medication regimen.

[0017] Preferably, the medication regimen display module uses points in the three-dimensional space of safety-effectiveness-economy to represent the evaluation results of each relevant medication regimen for display to the user.

[0018] The rheumatoid arthritis medication auxiliary system provided by the present invention can scientifically and comprehensively utilize the patient's historical treatment data to quickly and accurately recommend medication plans that meet the actual needs of current medical treatment. Through the technical solution of the present invention, it is possible to greatly shorten the time for doctors to weigh and decide on various medication plans to meet the personalized needs of rheumatoid arthritis patients, effectively improve the efficiency of medical staff in diagnosing and treating rheumatoid arthritis patients and the satisfaction of patients with medical plans. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required for use in the embodiments will be briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present application and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without paying creative work.

[0020] Figure 1 A schematic diagram of an auxiliary system for rheumatoid arthritis medication provided by the present invention in one embodiment. DETAILED DESCRIPTION

[0021] The technical solutions in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are only a part of the embodiments of the present application, rather than all of the embodiments. The components of the embodiments of the present application described and shown in the drawings here can be arranged and designed in various different configurations. Therefore, the following detailed description of the embodiments of the present application provided in the drawings is not intended to limit the scope of the application claimed for protection, but merely represents the selected embodiments of the present application. Based on the embodiments of the present application, all other embodiments obtained by those skilled in the art without making creative work belong to the scope of protection of the present application.

[0022] It should be noted that similar reference numerals and letters represent similar items in the following drawings, so once an item is defined in one drawing, it does not need to be further defined and explained in subsequent drawings. At the same time, in the description of this application, the terms "first", "second", etc. are only used to distinguish the description and cannot be understood as indicating or implying relative importance.

[0023] like Figure 1 As shown, in one embodiment, the auxiliary system 100 for rheumatoid arthritis medication provided by the present invention includes: a medication regimen acquisition module 101, a medication regimen analysis module 102, a medication regimen display module 103, a patient medication record library 104 and a drug database 105.

[0024] The patient medication record library 104 is used to record the patient medication records including the age of the rheumatoid arthritis patient, the severity of the disease during treatment, the medication regimen, and whether the patient's transaminase is abnormal during medication. The patient medication records in the patient medication record library 104 can come from one hospital, several hospitals, or a regional medical and health system.

[0025] The drug database 105 is used to record drug information and standard prices of each drug involved in the patient medication record in the patient medication record library 104. Each drug information may include the name, packaging, manufacturer, functional description and adverse reactions of each drug. The standard price of each drug is obtained according to a preset rule, which may be the price set during drug procurement, hospital price, or the average value calculated by relevant personnel according to relevant rules after market survey statistics.

[0026] The medication regimen acquisition module 101, based on the medical condition of the current patient input by the user (mainly the doctor), searches the patient medication record database for medication regimens with similar medical conditions in the patient medication records, as well as information on changes in the patient's condition during the implementation of the medication regimen and whether abnormalities in transaminase occur as evaluation information for the relevant medication regimen.

[0027] The above-mentioned current patient's medical condition mainly includes the severity of the patient's condition. In some embodiments, the current patient's medical condition is his current DAS28 score. The DAS28 evaluation standard is the current mainstream diagnostic standard for rheumatoid arthritis, which is quite scientific, comprehensive and authoritative for the evaluation of rheumatoid arthritis.

[0028] Accordingly, the medication regimen acquisition module 101 searches the patient medication records in the patient medication record library 104 for medication regimens that are in the same score range as the current DAS28 score, changes in the DAS28 score during the implementation of the medication regimen, and whether transaminase is abnormal as evaluation information of the relevant medication regimen.

[0029] In another embodiment, the medical condition includes the current DAS28 score and age of the current patient. Accordingly, the medication regimen acquisition module 101 searches the patient medication records in the patient medication record library 104 for medication regimens that are in the same age group as the patient and in the same score range as the current DAS28 score, changes in the DAS28 score during the implementation of the medication regimen, and whether the transaminase is abnormal as evaluation information of the relevant medication regimen.

[0030] Obviously, the medical condition may include not only the patient's age and DAS28 score, but also other basic information of the patient, such as the current medication regimen of patients who already have medication regimens. The information included in the medical condition will not be listed in detail here.

[0031] The medication regimen analysis module 102 evaluates the safety, effectiveness and economy of each relevant medication regimen based on the evaluation information of the relevant medication regimen, the drug information and standard price of each drug in the drug database 105 .

[0032] Furthermore, the medication regimen analysis module 102 obtains the safety score or grade of the relevant medication regimen based on whether the patient's transaminase is abnormal during the implementation of the relevant medication regimen, and the severity of the abnormal transaminase; and obtains the effectiveness score or grade of the relevant medication regimen based on the average monthly change in the patient's DAS28 score during the implementation of the relevant medication regimen. In addition, the medication regimen analysis module 102 uses the average monthly medication cost of the patient during the implementation of the relevant medication regimen as the economic evaluation result of the corresponding relevant medication regimen. The scores or grades of the three dimensions here can be obtained by performing an evaluation based on the set scoring criteria or grade evaluation criteria. No further details will be given here.

[0033] The medication scheme display module 103 is used to display the evaluation results of each relevant medication scheme by the medication scheme analysis module 102. In some embodiments, the medication scheme display module 103 uses points in the three-dimensional space of safety, effectiveness and economy to represent the evaluation results of each relevant medication scheme for display to the user.

[0034] Furthermore, the medication regimen display module 103 is also provided with a medication regimen screening submodule. The medication regimen screening submodule provides an input interface for the user to input the restriction conditions of the rheumatoid arthritis medication regimen, and screens out candidate medication regimens from the related medication regimens based on the restriction conditions input by the user. Based on the patient's current medication regimen and the medication adjustments required by the patient's condition, the three-dimensional evaluation of the medication regimen can provide decision-making assistance for adding or withdrawing medication according to the current patient's condition and the current medication regimen, and provide path suggestions for adding or withdrawing medication. The restriction conditions can be set by the doctor based on the patient's specific medication tendency, from the three aspects of safety, effectiveness and economy to screen out the corresponding part from the related medication regimen.

[0035] Corresponding to the above auxiliary system, another aspect of the present invention further provides a computer-readable storage medium. The computer-readable storage medium stores program codes, and when the program codes are executed by a computer or a processor, the functions of the above auxiliary system for rheumatoid arthritis medication are realized. The computer-readable storage medium includes but is not limited to RAM, ROM, sdram, flash, norflash and optical disks.

[0036] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application. Therefore, the protection scope of the present application shall be subject to the protection scope of the claims.

Claims

1. An auxiliary system for rheumatoid arthritis medication, characterized in that: The auxiliary system includes: a patient medication record library, a medication regimen acquisition module, a drug database, a medication regimen analysis module, and a medication regimen display module; The patient medication record database is used to record the patient medication records including the age of the rheumatoid arthritis patient, the severity of the disease during treatment, the medication regimen, and whether the patient's transaminase is abnormal during medication; A medication regimen acquisition module is used to search the patient medication record database for medication regimens with similar medical conditions based on the medical condition of the current patient input by the user, as well as information on changes in the severity of the disease during the implementation of the medication regimen and whether the transaminase is abnormal as evaluation information for the relevant medication regimen; The drug database is used to record the information of each drug and the standard price of the drug calculated according to preset rules; A medication regimen analysis module, which evaluates the safety, effectiveness, and economy of each relevant medication regimen based on the evaluation information of the relevant medication regimen and the drug database; The medication regimen display module is used to display the evaluation results of each relevant medication regimen by the medication regimen analysis module.

2. The assistance system according to claim 1, characterized in that The medical treatment status includes the current DAS28 score of the current patient; the medication regimen search module searches the patient medication records in the patient medication record library for medication regimens that are in the same score range as the current DAS28 score, changes in the DAS28 score during the implementation of the medication regimen, and whether the transaminase is abnormal as evaluation information of the relevant medication regimen.

3. The auxiliary system according to claim 1, characterized in that The medical condition includes the current DAS28 score and age of the current patient; the medication regimen search module searches the patient medication records in the patient medication record library for medication regimens that are in the same age group as the patient and in the same score range as the current DAS28 score, changes in the DAS28 score during the implementation of the medication regimen, and whether the transaminase is abnormal as evaluation information of the relevant medication regimen.

4. The assistance system according to claim 2 or 3, characterized in that: The medication regimen analysis module derives a safety score or grade of the relevant medication regimen based on whether the patient's transaminase is abnormal during the implementation of the relevant medication regimen and the severity of the transaminase abnormality.

5. The assistance system according to claim 4, characterized in that The medication regimen analysis module obtains the effectiveness score or grade of the relevant medication regimen based on the average monthly change in the DAS28 score of the patient during the implementation of the relevant medication regimen.

6. The auxiliary system according to claim 4, characterized in that The medication regimen analysis module derives an economic score or grade of the relevant medication regimen based on the patient's average monthly medication expenditure during the implementation of the relevant medication regimen.

7. The auxiliary system according to any one of claims 1 to 6, characterized in that: The medication regimen display module uses points in the three-dimensional space of safety, effectiveness and economy to represent the evaluation results of each relevant medication regimen and displays them to users.

8. The assistance system according to claim 7, characterized in that The medication regimen display module also has a medication regimen screening submodule; the medication regimen screening submodule provides an input interface for the user to input restriction conditions of the rheumatoid arthritis medication regimen, and screens out candidate medication regimens from the related medication regimens based on the restriction conditions input by the user; the restriction conditions are used to limit the scores or grades of the safety, effectiveness and economy of the rheumatoid arthritis medication regimen.

Images